TEX15 | Testis expressed 15 | | | | | | Group enriched |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted secreted proteins
| | | | | Group enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
ZCCHC12 | Zinc finger, CCHC domain containing 12 | | | | | | Group enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
RP11-167N24.6 | Uncharacterized protein | | | | | | Group enriched |
AGTR2 | Angiotensin II receptor, type 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
ITGA11 | Integrin, alpha 11 | Predicted membrane proteins
| | | | | Group enriched |
ITGB1BP2 | Integrin beta 1 binding protein (melusin) 2 | | | | | | Group enriched |
KIAA1644 | KIAA1644 | Predicted membrane proteins
| | | | | Group enriched |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Group enriched |
THBS4 | Thrombospondin 4 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ACTG2 | Actin, gamma 2, smooth muscle, enteric | Cytoskeleton related proteins
| | | | | Tissue enhanced |
AL031663.2 | CDNA FLJ26875 fis, clone PRS08969; Uncharacterized protein | | | | | | Tissue enhanced |
AP001579.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASPN | Asporin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
BNC2 | Basonuclin 2 | Transcription factors
| | | | | Tissue enhanced |
C3orf70 | Chromosome 3 open reading frame 70 | Cancer-related genes
| | | | | Tissue enhanced |
CHURC1-FNTB | CHURC1-FNTB readthrough | | | | | | Tissue enhanced |
CILP | Cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CNN1 | Calponin 1, basic, smooth muscle | Cancer-related genes Cytoskeleton related proteins
| | | | | Tissue enhanced |
COL4A6 | Collagen, type IV, alpha 6 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COL6A3 | Collagen, type VI, alpha 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
FAM83D | Family with sequence similarity 83, member D | | | | | | Tissue enhanced |
FBXL22 | F-box and leucine-rich repeat protein 22 | | | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GAL3ST3 | Galactose-3-O-sulfotransferase 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
GALR2 | Galanin receptor 2 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GJC1 | Gap junction protein, gamma 1, 45kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GLRA4 | Glycine receptor, alpha 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR161 | G protein-coupled receptor 161 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GREM1 | Gremlin 1, DAN family BMP antagonist | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
GRM7 | Glutamate receptor, metabotropic 7 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GUCY1A2 | Guanylate cyclase 1, soluble, alpha 2 | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
HAND1 | Heart and neural crest derivatives expressed 1 | Transcription factors
| | | | | Tissue enhanced |
HOXA10 | Homeobox A10 | Transcription factors
| | | | | Tissue enhanced |
HOXA11 | Homeobox A11 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOXC8 | Homeobox C8 | Transcription factors
| | | | | Tissue enhanced |
HOXD10 | Homeobox D10 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNE4 | Potassium voltage-gated channel, Isk-related family, member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |